CURE Pharmaceutical [OTC: CURR] Expands Highly Valuable Medication Patent Portfolio; Marketing Expansion to Mexico, Plus New Product Applications in the Multi-Billion Dollar Erectile Dysfunction Market

Innovative Medication Development & Enhancement Company. Patents for Extraction, Concentration & Processing of Specialized Medicinal Compounds. New Marketing to Mexico in Collaboration with Factoria Bogar Subsidiary. New Oral Thin Film Products for High Value Erectile Dysfunction Market. On June 3rd CURE Pharmaceutical (OTC:CURR), an innovative medication development and enhancement company,…